Although having a higher percentage of West African genetic ancestry was associated with shorter breast cancer DFS in this study, this finding was observed in the HR-positive/ERBB2-negative subgroup but not in the TNBC subgroup, suggesting that West African genetic ancestry may be differentially associated with survival outcomes based on IHC subtype. This evidence concerns the gene ERBB2 and breast cancer.